Complications and treatment of the myelodysplastic syndromes
- 31 January 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (1) , 117-121
- https://doi.org/10.1016/0145-2126(92)90110-s
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Clinical and Laboratory Precautions That Reduce the Adverse Reactions, Alloimmunization, Infectivity, and Possibly Immunomodulation Associated With Homologous TransfusionsTransfusion Medicine Reviews, 1990
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990
- Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary reportThe American Journal of Medicine, 1989
- Effects of purified human native granulocyte colony-stimulating factor (G-CSF) on proliferation of blast progenitors in acute myeloblastic leukemiaAmerican Journal of Hematology, 1988
- Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic SyndromesNew England Journal of Medicine, 1987
- Primary myelodysplastic syndrome and cancer.BMJ, 1987
- Immunological abnormalities in myelodysplastic syndromes II. COEXISTENT LYMPHOID OR PLASMA CELL NEOPLASMS: A REPORT OF 20 CASES UNRELATED TO CHEMOTHERAPYBritish Journal of Haematology, 1986
- Prognostic factors in the myelodysplastic syndromes: A reviewScandinavian Journal of Haematology, 1986
- Platelet Function in PreleukaemiaScandinavian Journal of Haematology, 1981
- Fever--a manifestation of preleukemiaJAMA, 1976